Sixth-year graduate student Alexandria Miller was awarded the Chairman’s Prize for her first-author paper accepted for publication in the January 28, 2012 issue of Science.
Eric Holland, Director of the Brain Tumor Center, is a neurosurgeon and researcher who studies the molecular changes that occur in glioblastoma and other brain tumors.
The Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences, Memorial Sloan-Kettering Cancer Center, has redesigned its website to enhance the experience of current and prospective students.
New studies investigate how the use of antibiotics affects the balance of both harmful and beneficial bacteria in patients undergoing stem cell transplantation.
A team of investigators from Memorial Sloan-Kettering has shown for the first time that tumor growth, metastasis, and chemotherapy resistance are connected to the same molecular changes inside breast cancer cells.
Memorial Sloan-Kettering investigators hope their new web tool will improve the accessibility of large-scale genome-sequencing information for cancer researchers everywhere, and accelerate research and therapeutic discovery.
Structural Biology Program Chair Nikola P. Pavletich and immunologist Alexander Y. Rudensky have received one of the highest honors given to scientists working in the United States.
As part of Memorial Sloan-Kettering’s 33rd annual academic convocation on May 11, the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences awarded PhDs to four graduates.
In an article describing the history and promise of immunotherapy for cancer treatment, the magazine highlights the groundbreaking work of James Allison, Chair of the Sloan-Kettering Institute’s Immunology Program, and medical oncologist and immunologist Jedd Wolchok.
As a child, Michael Kharas knew that he wanted to “be making the drugs doctors use to cure people.” Today he investigates molecular processes that stem cells and tumor cells have in common – in the hopes of uncovering insights for treatments for cancer and other diseases.
